Deutsche Bank
KYTH

Deutsche Bank’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Deutsche Bank’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-474,675
Closed -$35.6M – 5616
2015
Q3 		$35.6M Buy
474,675
+137,082
+41% +$10.2M 0.03% 608
2015
Q2 		$25.4M Buy
337,593
+77,232
+30% +$4.14M 0.02% 814
2015
Q1 		$13.1M Buy
260,361
+210,648
+424% +$8.84M 0.01% 1159
2014
Q4 		$1.72M Buy
49,713
+1,283
+3% +$44.8K ﹤0.01% 2788
2014
Q3 		$1.58M Buy
48,430
+37,472
+342% +$1.32M ﹤0.01% 2685
2014
Q2 		$419K Sell
10,958
-54,387
-83% -$1.9M ﹤0.01% 3599
2014
Q1 		$2.6M Buy
65,345
+17,593
+37% +$787K ﹤0.01% 2233
2013
Q4 		$1.78M Buy
47,752
+29,113
+156% +$1.21M ﹤0.01% 2349
2013
Q3 		$849K Buy
18,639
+9,088
+95% +$272K ﹤0.01% 3100
2013
Q2 		$256K Buy
+9,551
New +$219K ﹤0.01% 3659

Deutsche Bank's KYTH Position: Q4 2015 in Review

Deutsche Bank sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 474,675 shares — an estimated $35.6M sold.

Deutsche Bank first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $35.6M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Deutsche Bank reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Deutsche Bank sold 474,675 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $35.6M.
  • Deutsche Bank first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Deutsche Bank's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $35.6M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Deutsche Bank's 13F filing for Q4 2015, filed 16 Feb 2016.